Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy

There is a Blood Commentary on this article in this issue.

Gardado en:
Detalles Bibliográficos
Publicado en:Blood
Main Authors: Pemmaraju, Naveen, Kantarjian, Hagop, Nastoupil, Loretta, Dupuis, Megan, Zhou, Lisa, Pierce, Sherry, Patel, Keyur P., Masarova, Lucia, Cortes, Jorge, Verstovsek, Srdan
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2019
Assuntos:
Letter to Blood
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6634962/
https://ncbi.nlm.nih.gov/pubmed/30796023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2019-01-897637
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares